Shares of Alexion Pharmaceuticals Inc. rose more than 2% late Tuesday after the company announced the hiring of the former Biogen Inc. chief financial officer as its CFO. Paul J. Clancy will join Alexion on July 31 after having served as Biogen’s CFO for the past 10 years, the company said in a statement. Clancy succeeds Dave Anderson, who will continue to serve as CFO until July 31. “To ensure a smooth transition, (Anderson) will then become a Senior Advisor to the Chief Executive Officer and will remain with Alexion until the end of August,” the company said in a statement. Shares of Biogen fell 1.8%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News